Cancer cells need blood vessels to grow and spread throughout the body.
Without a supply of nutrients and oxygen delivered through new blood vessel formation—a process called angiogenesis—tumors would remain dormant and harmless.
Dr. William Li, a Harvard-trained physician and president of the Angiogenesis Foundation, has spent decades researching how everyday foods contain natural compounds that can block this blood vessel growth and potentially starve cancer cells.
His work builds on groundbreaking research from the 1970s and has contributed to over 40 FDA-approved treatments, while offering a practical, food-based approach anyone can implement today.
Jump to:
- The Foundation of Angiogenesis Research
- Understanding Angiogenesis and Cancer Growth
- Food as Anti-Angiogenic Medicine
- From Laboratory to FDA-Approved Treatments
- Clinical Perspective and Current Limitations
- Practical Applications for Health-Conscious Individuals
- The Intersection of Nutrition Science and Oncology
The Foundation of Angiogenesis Research
Dr. Judah Folkman, a Harvard surgeon, first proposed in 1971 that cancer could be treated by preventing tumors from growing blood vessels. His revolutionary paper in The New England Journal of Medicine suggested that cutting off blood supply could starve tumors before they became dangerous.
This theory challenged conventional thinking about cancer treatment at the time. Instead of directly attacking cancer cells with chemotherapy or radiation alone, Folkman envisioned targeting the support system tumors need to survive.
Dr. William Li trained under Folkman and became a leading voice in translating this research into practical applications. After completing his medical training at Harvard Medical School and Massachusetts General Hospital, Li co-founded the Angiogenesis Foundation in 1994 to advance this field.
Understanding Angiogenesis and Cancer Growth
Angiogenesis is a natural process where the body creates new blood vessels. This mechanism proves essential for wound healing, pregnancy, and normal growth throughout life.
Cancer cells, however, hijack this process. Tumors send out chemical signals that trigger excessive blood vessel formation, creating their own supply lines for nutrients and oxygen.
Without angiogenesis, microscopic tumors—which most people develop throughout their lives—remain dormant and unable to grow beyond the size of a pencil tip. They simply can’t access enough nutrients to expand or metastasize.
The Body’s Five Defense Systems
Li’s research identifies five critical defense systems working constantly to protect health:
- Angiogenesis regulation: Balancing blood vessel growth to prevent both excessive formation (cancer, obesity) and insufficient formation (heart disease, wounds that won’t heal)
- Stem cell maintenance: Regenerating damaged tissues and organs
- Microbiome health: Supporting beneficial gut bacteria that influence immunity and metabolism
- DNA protection: Repairing genetic damage that could lead to disease
- Immunity strengthening: Identifying and eliminating abnormal cells before they become problematic
Food as Anti-Angiogenic Medicine
Rather than focusing exclusively on pharmaceutical interventions, Li’s work highlights naturally occurring anti-angiogenic compounds found in common foods. These bioactive substances can help regulate blood vessel growth through regular dietary consumption.
His research spans over two decades and examines how specific foods influence angiogenesis at the molecular level. The goal isn’t to replace conventional cancer treatment but to provide complementary strategies for prevention and support.
Li authored “Eat to Beat Disease” in 2019, translating complex scientific findings into actionable dietary recommendations. His TED Talk on the subject has reached over 11 million viewers, demonstrating widespread interest in food-based approaches to health.
Which Foods Show Anti-Angiogenic Properties?
Laboratory studies and clinical research have identified numerous foods containing compounds that may inhibit abnormal blood vessel formation:
- Green tea: Contains catechins that interfere with signaling pathways tumors use to stimulate blood vessel growth
- Berries: Rich in ellagic acid and anthocyanins with demonstrated anti-angiogenic effects
- Tomatoes: Lycopene content may reduce blood vessel formation in precancerous tissues
- Soy products: Genistein acts on multiple pathways involved in angiogenesis
- Dark chocolate: Flavonoids show promise in regulating vascular growth
- Cruciferous vegetables: Compounds like sulforaphane influence angiogenic factors
From Laboratory to FDA-Approved Treatments
Li’s research has contributed to the development of over 40 FDA-approved treatments utilizing anti-angiogenic principles. These medications target specific molecular pathways that tumors exploit to create blood vessels.
Drugs like bevacizumab (Avastin), sunitinib, and sorafenib represent direct applications of angiogenesis research in oncology. They work by blocking vascular endothelial growth factor (VEGF) and other signals cancer cells use to stimulate blood vessel formation.
However, pharmaceutical interventions come with side effects and costs that food-based approaches don’t carry. This creates compelling reasons to explore dietary strategies alongside medical treatment.
Clinical Perspective and Current Limitations
Medical oncologists emphasize that food-based anti-angiogenic compounds should complement established cancer treatments rather than replace them. No dietary approach has demonstrated the ability to cure existing cancers on its own.
Nutritional scientists note that while laboratory studies show promising mechanisms, more human clinical trials are needed. The concentrations of bioactive compounds tested in controlled settings may differ significantly from amounts obtained through normal eating patterns.
Clinical researchers stress the importance of rigorous testing protocols. Observational studies showing correlations between certain foods and reduced cancer risk don’t necessarily prove causation.
The Evidence Gap
While laboratory research demonstrates how specific compounds affect angiogenesis in cell cultures and animal models, translating these findings to human health outcomes requires extensive investigation. Factors like bioavailability, metabolism, and individual variation all influence whether foods produce meaningful anti-angiogenic effects in living people.
Despite these limitations, the safety profile of whole foods makes them reasonable additions to cancer prevention strategies. Unlike pharmaceutical interventions, increasing consumption of vegetables, fruits, and other nutrient-dense foods carries minimal risk.
Practical Applications for Health-Conscious Individuals
Li’s work at the Angiogenesis Foundation, established in 1994, focuses on making scientific discoveries accessible and actionable. His faculty appointments at Harvard Medical School, Tufts University, and Dartmouth Medical School lend credibility to recommendations.
For cancer patients and survivors seeking complementary approaches, incorporating anti-angiogenic foods represents a low-risk strategy worth discussing with healthcare providers. These dietary changes may support conventional treatments without interfering with them.
Healthcare professionals exploring integrative medicine can use this research to guide patient conversations about nutrition and cancer prevention. Evidence-based recommendations carry more weight than anecdotal claims.
Building an Anti-Angiogenic Plate
Rather than focusing on individual “superfoods,” Li’s approach emphasizes dietary diversity. Combining multiple sources of anti-angiogenic compounds may produce synergistic effects greater than any single food alone.
Meals rich in colorful vegetables, fruits, whole grains, legumes, and moderate amounts of foods like green tea and dark chocolate align with both anti-angiogenic research and broader nutritional guidelines. This overlap suggests that eating for angiogenesis control supports overall health simultaneously.
The Intersection of Nutrition Science and Oncology
Dr. Li’s work represents growing recognition that food influences disease processes at fundamental biological levels. The field of functional foods and nutraceuticals continues expanding as researchers identify bioactive compounds with therapeutic potential.
Clinical trials testing food-based interventions for cancer prevention are increasing in number and sophistication. These studies examine not just whether people who eat certain foods have better outcomes, but why those foods might provide protection.
Understanding mechanisms—like angiogenesis inhibition—allows for more targeted dietary recommendations. Instead of vague advice to “eat healthy,” researchers can specify which compounds in which foods affect which biological processes.
This precision approach to nutrition bridges the gap between traditional dietary guidelines and personalized medicine. As research advances, recommendations may become increasingly tailored to individual risk factors and genetic profiles.
